Covid testing: the ‘great new game of holiday roulette’
On one day last week, the price of a private PCR test ranged from £23.99 to £575
“Like many people, I’ve spent a lot of this year playing the great new game of holiday roulette,” said Rachel Cooke in The Guardian. It began in January when a group of us gambled on booking a house in rural France. Our bet appeared to pay off last week when France was put back on the amber list, meaning that fully vaccinated Britons can visit the country without having to quarantine on their return. But my friends and I are now caught up in another game: negotiating our way through the confusing rules on Covid tests.
It’s a complex business, said Janet Street-Porter in The Independent. For most purposes, cheap lateral flow tests are deemed sufficient. But even fully vaccinated people have to take more expensive PCR tests two days after returning to the UK from amber and green countries (and those returning from Spain now need to have a pre-flight PCR test as well). “Is the Prime Minister’s long-term plan to make foreign holidays so unattractive that we give up, stay at home and spend our cash in UK PLC, propping up Rishi’s sagging coffers?”
The testing regime is certainly chaotic, said Charlotte Lytton in The Daily Telegraph. The Government’s website features a list of hundreds of private PCR test providers charging wildly different rates: on one day last week, the prices ranged from £23.99 to £575 for the same test.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Tales abound of people ordering home testing kits that never arrive, or of booking virtual appointments that don’t happen. Many others have been sent result certificates that are either riddled with errors or too late to stop people with Covid from spreading it, or to catch flights. Tests returned by travellers after their trips were recently pictured piling up and spilling out onto the street at drop-off points belonging to the operator Randox.
Ministers have justified their insistence on PCR tests on the basis that these more sophisticated tests involve gene sequencing that can help identify troubling new variants from abroad, said the Daily Mail. But that argument has been blown “out of the water” by the recent revelation that only 5% of the tests are actually being sent for analysis.
It’s good that the Government has partially simplified the travel system by scrapping the amber-plus list – and that it ditched the idea of a new “amber watch” category – but it now needs to go further. At the very least, PCR tests should be price-capped and made VAT-free. It would be better, though, to make lateral flow tests the norm, at least for double-jabbed travellers. Best of all would be to follow the lead of France and the other European nations that now allow “fully vaccinated arrivals to enter their country without proof of a negative test of any sort”.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
A beginner's guide to exploring the Amazon
The Week Recommends Trek carefully — and respectfully — in the world's largest rainforest
By Catherine Garcia, The Week US Published
-
What is the future of the International Space Station?
In the Spotlight A fiery retirement, launching the era of private space stations
By Joel Mathis, The Week US Published
-
What are the rules of a no-buy vs. low-buy year?
The Explainer These two revised approaches to purchasing could help you save big
By Becca Stanek, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
New Alzheimer's drug rejected: is Nice being nasty?
Talking Point Health watchdog has announced lecanemab will be denied to NHS patients on cost grounds
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Last updated
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published